Race for new antibiotics: future success is hanging by a thread
It’s been four decades since we’ve had a new class of antibiotics. Yet across the world, the number of people suffering from drug-resistant infections continues to rise at an alarming rate.
The world desperately needs new antibiotics – they are the foundation of modern medicine.
Without new antibiotics, infections like blood poisoning, gonorrhoea and urinary tract infections risk becoming untreatable. More people will suffer fatal complications from routine medical procedures like chemotherapy or organ transplants.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
